Softgel Capsules Market Size, Share, Analysis, Trends, Growth, Forecast 2032
Softgel Capsules Market Analysis By Product (Gelatin Softgel Capsule and Non-gelatin Softgel Capsule), By End-User (Pharmaceutical Companies and Contract Manufacturing Organizations), By Application (Anti-inflammatory Drugs, Antibiotic drugs, Health Supplements, and Cardiovascular Drugs), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024 - 2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 2.67 Billion | USD 4.24 Billion | 5.3% | 2023 |
Table Of Content
- Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodulogy
- 1.3.1. Market Research Type
- 1.3.2. Market Research Methodulogy
- Chapter 2. Executive Summary
- 2.1. Softgel Capsules Market, 2018–2028(USD Billion)
- 2.2. Softgel Capsules Market: Snapshot
- Chapter 3. Global Softgel Capsules Market– Industry Analysis
- 3.1. Softgel Capsules Market: Market Dynamics
- 3.2. Market Drivers
- 3.2.1. Drug suspension with unpleasant odor can be ingested easily in the softgel capsule as the product offers convenient consumption, thereby multiplying growth of softgel capsules industry.
- 3.2.2. Increase in consumer inclination towards the product due to its self-lubricating chafracteristic as well as its availability in various sizes, chewable & meltable forms, and myriad culors will supplement expansion of softgel capsules market.
- 3.3. Porter’s Five Forces Analysis
- 3.4. Market Attractiveness Analysis
- 3.4.1. Market attractiveness analysis By Product
- 3.4.2. Market attractiveness analysis By End-User
- 3.4.3. Market attractiveness analysis By Application
- Chapter 4. Global Softgel Capsules Market– Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global Softgel Capsules Market: company market share, 2019
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New Product launches
- 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4. Research and development and Regional expansion
- 4.3. Price trend analysis
- 4.1. Company market share analysis
- Chapter 5. Global Softgel Capsules Market– Product Analysis
- 5.1. Global Softgel Capsules Marketoverview: By Product
- 5.1.1. Global Softgel Capsules Marketshare, By Product, 2020 and 2028
- 5.2. Non-gelatin Softgel Capsule
- 5.2.1. Global Softgel Capsules Marketby Non-gelatin Softgel Capsule, 2018–2028(USD Billion)
- 5.3. Gelatin Softgel Capsule
- 5.3.1. Global Softgel Capsules Marketby Gelatin Softgel Capsule, 2018–2028(USD Billion)
- 5.1. Global Softgel Capsules Marketoverview: By Product
- Chapter 6. Global Softgel Capsules Marketoverview: By End-User
- 6.1.1. Global Softgel Capsules Marketshare, By End-User, 2020 and 2028
- 6.2. Pharmaceutical Companies
- 6.2.1. Global Softgel Capsules Marketby Pharmaceutical Companies , 2018–2028(USD Billion)
- 6.3. Contract Manufacturing Organizations
- 6.3.1. Global Softgel Capsules Marketby Contract Manufacturing Organizations, 2018–2028(USD Billion)
- Chapter 7. Global Softgel Capsules Marketoverview: By Application
- 7.1.1. Global Softgel Capsules Market share, By Application, 2020 and 2028
- 7.2. Anti-inflammatory Drugs
- 7.2.1. Global Softgel Capsules Marketby Anti-inflammatory Drugs, 2018–2028(USD Billion)
- 7.3. Antibiotic drugs
- 7.3.1. Global Softgel Capsules Marketby Antibiotic drugs, 2018–2028(USD Billion)
- 7.4. Cardiovascular Drugs
- 7.4.1. Global Softgel Capsules Marketby Cardiovascular Drugs, 2018–2028(USD Billion)
- 7.5. Health Supplements
- 7.5.1. Global Softgel Capsules Marketby Health Supplements, 2018–2028(USD Billion)
- Chapter 8. Company Profiles
- 8.1. Catalent, Inc.
- 8.1.1. Overview
- 8.1.2. Financials
- 8.1.3. Product Portfulio
- 8.1.4. Business Strategy
- 8.1.5. Recent Developments
- 8.2. Capsugel
- 8.2.1. Overview
- 8.2.2. Financials
- 8.2.3. Product Portfulio
- 8.2.4. Business Strategy
- 8.2.5. Recent Developments
- 8.3. Elnova Pharma
- 8.3.1. Overview
- 8.3.2. Financials
- 8.3.3. Product Portfulio
- 8.3.4. Business Strategy
- 8.3.5. Recent Development
- 8.4. Hunan ER-KANG Pharmaceutical Co Ltd.
- 8.4.1. Overview
- 8.4.2. Financials
- 8.4.3. Product Portfulio
- 8.4.4. Business Strategy
- 8.4.5. Recent Development
- 8.5. Aenova Group GmbH
- 8.5.1. Overview
- 8.5.2. Financials
- 8.5.3. Product Portfulio
- 8.5.4. Business Strategy
- 8.5.5. Recent Development
- 8.6. Guangdong Yichao Biulogical Co., Ltd.
- 8.6.1. Overview
- 8.6.2. Financials
- 8.6.3. Product Portfulio
- 8.6.4. Business Strategy
- 8.6.5. Recent Development
- 8.7. Sirio Pharma Company Ltd
- 8.7.1. Overview
- 8.7.2. Financials
- 8.7.3. Product Portfulio
- 8.7.4. Business Strategy
- 8.7.5. Recent Development
- 8.8. Captek Softgel International Inc.
- 8.8.1. Overview
- 8.8.2. Financials
- 8.8.3. Product Portfulio
- 8.8.4. Business Strategy
- 8.8.5. Recent Development
- 8.9. Fuji Capsule Co., Ltd.
- 8.9.1. Overview
- 8.9.2. Financials
- 8.9.3. Product Portfulio
- 8.9.4. Business Strategy
- 8.9.5. Recent Development
- 8.10. EuroCaps Ltd.
- 8.10.1. Overview
- 8.10.2. Financials
- 8.10.3. Product Portfulio
- 8.10.4. Business Strategy
- 8.10.5. Recent Development
- 8.11. KD Pharma Group
- 8.11.1. Overview
- 8.11.2. Financials
- 8.11.3. Product Portfulio
- 8.11.4. Business Strategy
- 8.11.5. Recent Development
- 8.1. Catalent, Inc.
Table Of Figures
List of Figures
1. Market research Type
2. Market research methodology
3. Global Clinical Trial Supply and Logistics Market, 2018–2028(USD Billion)
4. Porter’s Five Forces Analysis
5. Global Clinical Trial Supply and Logistics Marketattractiveness, By Product
6. Global Clinical Trial Supply and Logistics Marketattractiveness, By End-User
7. Global Clinical Trial Supply and Logistics Marketattractiveness by Application
8. Global Clinical Trial Supply and Logistics Marketshare by Product ,2020 and 2028 (USD Billion)
9. Global Clinical Trial Supply and Logistics Marketby Non-gelatin Softgel Capsule, 2018–2028(USD Billion)
10. Global Clinical Trial Supply and Logistics Marketby Gelatin Softgel Capsule, 2018–2028(USD Billion)
11. Global Clinical Trial Supply and Logistics Marketshare by End-User ,2020 and 2028 (USD Billion)
12. Global Clinical Trial Supply and Logistics Marketby Pharmaceutical Companies, 2018–2028(USD Billion)
13. Global Clinical Trial Supply and Logistics Marketby Contract Manufacturing Organizations, 2018–2028(USD Billion)
14. Global Clinical Trial Supply and Logistics Marketshare by Application ,2020 and 2028 (USD Billion)
15. Global Clinical Trial Supply and Logistics Marketby Anti-inflammatory Drugs, 2018–2028(USD Billion)
16. Global Clinical Trial Supply and Logistics Marketby Antibiotic drugs, 2018–2028(USD Billion)
17. Global Clinical Trial Supply and Logistics Marketby Health Supplements, 2018–2028(USD Billion)
18. Global Clinical Trial Supply and Logistics Marketby Cardiovascular Drugs, 2018–2028(USD Billion)
19. Global Clinical Trial Supply and Logistics Marketshare, by Region, 2020 and 2028
20. North America Clinical Trial Supply and Logistics Market, 2018–2028(USD Billion)
21. Europe Clinical Trial Supply and Logistics Market, 2018–2028(USD Billion)
22. Asia Pacific Clinical Trial Supply and Logistics Market, 2018–2028(USD Billion)
23. Latin America Clinical Trial Supply and Logistics Market, 2018–2028(USD Billion)
24. The Middle East and Africa Clinical Trial Supply and Logistics Market, 2018–2028(USD Billion)
Table Of Tables
List of Tables
1. Global Clinical Trial Supply and Logistics Market: snapshot
2. Drivers of the Clinical Trial Supply and Logistics Market: impact analysis
3. North America Softgel Capsules Marketrevenue, By Product ,2018–2028(USD Billion)
4. North America Softgel Capsules Marketrevenue, By End-User ,2018–2028(USD Billion)
5. North America Softgel Capsules Marketrevenue, By Application ,2018–2028(USD Billion)
6. The U.S. Softgel Capsules Marketrevenue, By Product ,2018–2028(USD Billion)
7. The U.S. Softgel Capsules Marketrevenue, By End-User ,2018–2028(USD Billion)
8. The U.S. Softgel Capsules Marketrevenue, By Application ,2018–2028(USD Billion)
9. Rest of North America Softgel Capsules Marketrevenue, By Product ,2018–2028(USD Billion)
10. Rest of North America Softgel Capsules Marketrevenue, By End-User ,2018–2028(USD Billion)
11. Rest of North America Softgel Capsules Marketrevenue, By Application ,2018–2028(USD Billion)
12. Europe Softgel Capsules Marketrevenue, By Product ,2018–2028(USD Billion)
13. Europe Softgel Capsules Marketrevenue, By End-User ,2018–2028(USD Billion)
14. Europe Softgel Capsules Marketrevenue, By Application ,2018–2028(USD Billion)
15. UK Softgel Capsules Marketrevenue, By Product ,2018–2028(USD Billion)
16. UK Softgel Capsules Marketrevenue, By End-User ,2018–2028(USD Billion)
17. UK Softgel Capsules Marketrevenue, By Application ,2018–2028(USD Billion)
18. France Softgel Capsules Marketrevenue, By Product ,2018–2028(USD Billion)
19. France Softgel Capsules Marketrevenue, By End-User ,2018–2028(USD Billion)
20. France Softgel Capsules Marketrevenue, By Application ,2018–2028(USD Billion)
21. Germany Softgel Capsules Marketrevenue, By Product ,2018–2028(USD Billion)
22. Germany Softgel Capsules Marketrevenue, By End-User ,2018–2028(USD Billion)
23. Germany Softgel Capsules Marketrevenue, By Application ,2018–2028(USD Billion)
24. Rest of Europe Softgel Capsules Marketrevenue, By Product ,2018–2028(USD Billion)
25. Rest of Europe Softgel Capsules Marketrevenue, By End-User ,2018–2028(USD Billion)
26. Rest of Europe Softgel Capsules Marketrevenue, By Application ,2018–2028(USD Billion)
27. Asia Pacific Softgel Capsules Marketrevenue, By Product ,2018–2028(USD Billion)
28. Asia Pacific Softgel Capsules Marketrevenue, By End-User ,2018–2028(USD Billion)
29. Asia Pacific Softgel Capsules Marketrevenue, By Application ,2018–2028(USD Billion)
30. China Softgel Capsules Marketrevenue, By Product ,2018–2028(USD Billion)
31. China Softgel Capsules Marketrevenue, By End-User ,2018–2028(USD Billion)
32. China Softgel Capsules Marketrevenue, By Application ,2018–2028(USD Billion)
33. Japan Softgel Capsules Marketrevenue, By Product ,2018–2028(USD Billion)
34. Japan Softgel Capsules Marketrevenue, By End-User ,2018–2028(USD Billion)
35. Japan Softgel Capsules Marketrevenue, By Application ,2018–2028(USD Billion)
36. India Softgel Capsules Marketrevenue, By Product ,2018–2028(USD Billion)
37. India Softgel Capsules Marketrevenue, By End-User ,2018–2028(USD Billion)
38. India Softgel Capsules Marketrevenue, By Application ,2018–2028(USD Billion)
39. Rest of Asia Pacific Softgel Capsules Marketrevenue, By Product ,2018–2028(USD Billion)
40. Rest of Asia Pacific Softgel Capsules Marketrevenue, By End-User ,2018–2028(USD Billion)
41. Rest of North America Softgel Capsules Marketrevenue, By Application ,2018–2028(USD Billion)
42. Latin America Softgel Capsules Marketrevenue, By Product ,2018–2028(USD Billion)
43. Latin America Softgel Capsules Marketrevenue, By End-User ,2018–2028(USD Billion)
44. Latin America Softgel Capsules Marketrevenue, By Application ,2018–2028(USD Billion)
45. Brazil Softgel Capsules Marketrevenue, By Product ,2018–2028(USD Billion)
46. Brazil Softgel Capsules Marketrevenue, By End-User ,2018–2028(USD Billion)
47. Brazil Softgel Capsules Marketrevenue, By Application ,2018–2028(USD Billion)
48. Rest of Latin America Softgel Capsules Marketrevenue, By Product ,2018–2028(USD Billion)
49. Rest of Latin America Softgel Capsules Marketrevenue, By End-User ,2018–2028(USD Billion)
50. Rest of Latin America Softgel Capsules Marketrevenue, By Application ,2018–2028(USD Billion)
51. The Middle East and Africa Softgel Capsules Marketrevenue, By Product ,2018–2028(USD Billion)
52. The Middle East and Africa Softgel Capsules Marketrevenue, By End-User ,2018–2028(USD Billion)
53. The Middle East and Africa Softgel Capsules Marketrevenue, By Application ,2018–2028(USD Billion)
54. Saudi Arabia Softgel Capsules Marketrevenue, By Product ,2018–2028(USD Billion)
55. Saudi Arabia Softgel Capsules Marketrevenue, By End-User ,2018–2028(USD Billion)
56. Saudi Arabia Softgel Capsules Marketrevenue, By Application ,2018–2028(USD Billion)
57. South Africa Softgel Capsules Marketrevenue, By Product ,2018–2028(USD Billion)
58. South Africa Softgel Capsules Marketrevenue, By End-User ,2018–2028(USD Billion)
59. South Africa Softgel Capsules Marketrevenue, By Application ,2018–2028(USD Billion)
60. Rest of the Middle East & Africa Softgel Capsules Marketrevenue, By Product ,2018–2028(USD Billion)
61. Rest of the Middle East & Africa Softgel Capsules Marketrevenue, By End-User ,2018–2028(USD Billion)
62. Rest of the Middle East & Africa Softgel Capsules Marketrevenue, By Application ,2018–2028(USD Billion)
Methodology
FrequentlyAsked Questions
Softgel capsule is utilized for preventing vitamin deficiency arising due to poor diet and certain kinds of illness. In addition to this, it is easily soluble and can help in delivering ultra-low doses of low melting compound. Moreover, it generates less dust during production, thereby ensuring safety of workers. Apart from this, the drug suspensions with unpleasant taste or odor can be ingested easily in the softgel capsule as the latter provides convenient ingestion. All these aforementioned are anticipated to boost growth of softgel capsules market.
Furthermore, softgel capsules enhance melatonin bioavailability in human beings. Moreover, beneficial features of the product include solubility and tiny particle size. These products possess high dosage accuracy as well as uniformity stability. It can improve bioavailability of poorly soluble medicines. Rise in consumer preference for the product due to its self-lubricating feature as well as its availability in myriad sizes, forms like chewable & meltable forms, and colors will aid growth of softgel capsules market.
Softgel Capsules Market size worth at USD 2.67 Billion in 2023 and projected to USD 4.24 Billion by 2032, with a CAGR of around 5.3% between 2024-2032.
Europe will contribute lucratively towards the regional market size over the estimated timeline. The regional market surge is subject to large-scale funding of research activities pertaining to manufacture of softgel capsules in different European countries. Moreover, Gelatin has been recognized as GRAS (Generally Recognized As Safe) food ingredient by FDA and this has proved to be a key growth factor for softgel capsules market in Europe. Increase in product sales and addition of new products to existing product line will chart a profitable growth path for softgel capsules industry in Europe over years to come.
The key market participants include Catalent, Inc., Capsugel, Elnova Pharma, Hunan ER-KANG Pharmaceutical Co Ltd., Aenova Group GmbH, Guangdong Yichao Biological Co., Ltd., Sirio Pharma Company Ltd, Captek Softgel International Inc, Fuji Capsule Co., Ltd., EuroCaps Ltd., and KD Pharma Group.
RelatedNews
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed